Novel Process
AssigneesGlaxoSmithKline Consumer Healthcare Holdings (US) LLC, GlaxoSmithKline Consumer Healthcare (UK) IP Limited
InventorsJohn Benjamin JONES, Richard Matthew John FINLAY, Paul John HEATH, Mayur P. LODAYA
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of extrusion technology in a process for the low-moisture continuous gelatinisation and the enzymatic hydrolysis of flour to provide a dextrinised product having a dextrose equivalent (DE) of at least 15 and to a process for drying a dextrinised product.
Claims19
A process for gelatinisation and the enzymatic hydrolysis of flour which comprises passing said flour through a twin-screw extruder in the presence of about 0.025% to about 1.5% w/w relative to flour of a hydrolytic enzyme and in the presence of water at a moisture level from about 30% to about 45% w/w relative to the total quantity of ingredients, at a screw speed from about 300 RPM to about 800 RPM and a temperature in the range from about 80° C. to about 160° C.;
- the dimensions of the extruder being such that the residence time of the flour through the extruder is from about 60 to about 12 seconds resulting in a dextrinised product having a dextrose equivalent of at least 15.
(canceled)
(canceled)
Dependencies are inferred from the claim text.